Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesSmall dense LDL and VLDL predict common carotid artery IMT and elicit an inflammatory response in peripheral blood mononuclear and endothelial cells
Atherosclerosis, 10/15/09
Norata GD et al. – LDL–relative flotation rate significantly correlates with several cardiometabolic parameters. Furthermore cholesterol levels lipoprotein subfractions within the TGRL and sdLDL density range are independent predictors of IMT variance and are associated with a pro–inflammatory activation of PBMC and endothelial cells.
Related Articles
Coronary artery endothelial dysfunction is positively correlated with low density lipoprotein and inversely correlated with high density lipoprotein subclass particles measured by nuclear magnetic resonance spectroscopy
Atherosclerosis, 11/12/09
Relevance Score: 69%
Management of Hypercholesterolemia
Geriatrics & Aging, 11/12/09
Relevance Score: 68%
Effectiveness of rosuvastatin in reducing LDL-C and target LDL-C goal attainment in real-world clinical practice
Current Medical Research and Opinion, 10/22/09
Relevance Score: 68%
Metabolism of Very-Low-Density Lipoprotein and Low-Density Lipoprotein Containing Apolipoprotein C-III and Not Other Small Apolipoproteins
Arteriosclerosis, Thrombosis, and Vascular Biology, 11/17/09
Relevance Score: 67%
Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
Vascular Health and Risk Management, 11/03/09
Relevance Score: 67%
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Candesartan reduces the innate immune response to lipopolysaccharide in human monocytes
Journal of Hypertension, 11/25/09
The High Prevalence of Subclinical Atherosclerosis in Patients With Ankylosing Spondylitis Without Clinically Evident Cardiovascular Disease
Medicine, 11/20/09
Today in Inflammation...keeping you current
Receive free subspecialty "5-minute updates" via email
Relationship Between Baseline Inflammatory Markers, Antiplate let Therapy, and Adverse Cardiac Events After Percutaneous Coronary Intervention
Circulation: Cardiovascular Interventions, 11/24/09
The TIR/BB-loop mimetic AS-1 protects the myocardium from ischaemia/reperfusion injury
Cardiovascular Research, 11/20/09
Spironolactone and Chlorthalidone in Uncontrolled Elderly Hypertensive Patients Treated with Calcium Antagonists and Angiotensin II Receptor-Blocker: Effects on Endothelial Function, Inflammation, and Oxidative Stress
Clinical and Experimental Hypertension, 11/19/09
Sponsor
Article Search
Sponsor
Sponsor